共 50 条
- [45] Oncogenic enhancer of zeste homolog 2 is an actionable target in patients with non-small cell lung cancer CANCER MEDICINE, 2019, 8 (14): : 6383 - 6392
- [50] Personalizing non-small cell lung cancer treatment through patient-derived xenograft models: preclinical and clinical factors for consideration CLINICAL & TRANSLATIONAL ONCOLOGY, 2024, 26 (09): : 2227 - 2239